Source Post

CNBC Committee Debates If Tech Stocks Have Fallen Enough (2 OVERSOLD Growth Stocks To BUY Now)

The CNBC investment committee debated the tech sector's future, questioning AI demand and noting the Mag 7's negative performance year-to-date. The creator highlights that while tech is messy, other sectors like retail (Casey's, Starbucks, Darden, Best Buy) and industrials (Materion, Albany International) are showing strength, suggesting opportunities outside of beaten-down tech. The consensus is that it's too early to buy the tech dip, with a shift towards value and forgotten stocks already underway.

Linked Mentions

Tickers discussed in this post

LMNDBullishMedium ConvictionSignal-backedPrimary

Lemonade (LMND) is presented as an oversold growth stock poised to reward patient investors by reinventing the insurance industry with AI.

MUNeutralMedium ConvictionSignal-backedSecondary

Micron's prior run-up was due to an earnings paradigm shift, but a pullback is being re-evaluated for sustainable growth.

NVDANeutralLow ConvictionResearch Only

Nvidia is down from its 52-week high, as are other major tech stocks, indicating selling pressure.

AMZNNeutralLow ConvictionResearch Only

Amazon has seen a 12% decline from its 52-week high, contributing to the broader tech pullback.

METANeutralLow ConvictionResearch Only

Meta is noted to be down 27% from its 52-week high, reflecting recent market weakness.

MSFTNeutralLow ConvictionResearch Only

Microsoft is mentioned as being 27% off its 52-week high, indicating a significant pullback.

MTRNBullishMedium ConvictionSignal-backedSecondary

Materion, a materials company, is performing well within the growth strategy, indicating strength in specialized industrial sectors.

LAMRBullishMedium ConvictionSignal-backedSecondary

Lamar Advertising, a billboard company, is performing strongly with significant year-to-date gains, highlighting opportunities outside of tech.

RHPBullishMedium ConvictionSignal-backedSecondary

Ryman Hospitality Properties is performing very well, with stocks up 60-80% on the year, indicating strong performance in non-tech sectors.

IBIONeutralLow ConvictionResearch Only

iBio is mentioned as a biotech stock that has gained 7% in the past week, showing that opportunities exist in various sectors.

Linked Signals

Tracked calls opened from this post

No linked signals were opened directly from this post.